US Patent Issued to SCARCELL Therapeutics on May 12 for "Mammalian cell population and medicaments for cell therapies in humans and improved cell cultivation methods" (French Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,341, issued on May 12, was assigned to SCARCELL Therapeutics (Paris).

"Mammalian cell population and medicaments for cell therapies in humans and improved cell cultivation methods" was invented by Antoine Lafont (Paris) and Mathieu Castela (Clamart, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions of matter, including cell populations and medicaments, are provided that are derived from human gingival fibroblasts and have cell phenotypes that occur in proportions not found in natural gum tissue, but rather, are preferentially are selected to express proteins favoring angiogenesis and anti-inflammatory effects, while reducing cell pop...